JTX-8064
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JTX-8064, covering 2024-04-09 to 2024-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors [Phase 1, Phase 2]